Hydrocortisone with Aloe

Product NDC
0472-0339
11-digit product format
004720339
Labeler code
0472
Product ID
0472-0339_f08adb32-103c-4972-8ede-741bd7765e7b
Type
HUMAN OTC DRUG
Nonproprietary name
Hydrocortisone
Dosage form
CREAM
Route
TOPICAL
Labeler
Actavis Pharma, Inc.
Application
part348
Marketing category
OTC MONOGRAPH NOT FINAL
Marketing start
1997-09-01
Marketing end
2022-11-30
Substance
HYDROCORTISONE
Active strength
1 g/100g
Pharmacologic classes
Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct0472-0339DDiscontinued by firm2026-10-12
excluded packagepackage0472-03390472-0339-56DDiscontinued by firm2026-10-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage0472-0339-56d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage0472-0339-56f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage0472-0339-562ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage0472-0339-56a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage0472-0339-56cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage0472-0339-56cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage0472-0339-56302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage0472-0339-56ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage0472-0339-560efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage0472-0339-56ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproduct367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage0472-0339-56367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproduct557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage0472-0339-56557ba5c1ecfa…9c80585c8c6e…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0472-0339-56GM - Gram0472-0339edc0898e-f458-4de3-a426-4f52e4ef7bdd12012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
HYDROCORTISONEACTIVE INGREDIENTWI4X0X7BPJHYDROCORTISONE MAXIMUM STRENGTH (HYDROCORTISONE) CREAM [PREFERRED PHARMACEUTICALS, INC.]2
HYDROCORTISONEACTIVE INGREDIENTWI4X0X7BPJHYDROCORTISONE WITH ALOE MAXIMUM STRENGTH (HYDROCORTISONE) CREAM [ACTAVIS MID ATLANTIC LLC]2
HYDROCORTISONEACTIVE MOIETYWI4X0X7BPJHYDROCORTISONE MAXIMUM STRENGTH (HYDROCORTISONE) CREAM [PREFERRED PHARMACEUTICALS, INC.]2
HYDROCORTISONEACTIVE MOIETYWI4X0X7BPJHYDROCORTISONE WITH ALOE MAXIMUM STRENGTH (HYDROCORTISONE) CREAM [ACTAVIS MID ATLANTIC LLC]2
ALOE VERA LEAFINACTIVE INGREDIENTZY81Z83H0XHYDROCORTISONE WITH ALOE MAXIMUM STRENGTH (HYDROCORTISONE) CREAM [ACTAVIS MID ATLANTIC LLC]2
ALOE VERA LEAFINACTIVE INGREDIENTZY81Z83H0XHYDROCORTISONE MAXIMUM STRENGTH (HYDROCORTISONE) CREAM [PREFERRED PHARMACEUTICALS, INC.]2
CETYL ALCOHOLINACTIVE INGREDIENT936JST6JCNHYDROCORTISONE MAXIMUM STRENGTH (HYDROCORTISONE) CREAM [PREFERRED PHARMACEUTICALS, INC.]2
CETYL ALCOHOLINACTIVE INGREDIENT936JST6JCNHYDROCORTISONE WITH ALOE MAXIMUM STRENGTH (HYDROCORTISONE) CREAM [ACTAVIS MID ATLANTIC LLC]2
CITRIC ACID MONOHYDRATEINACTIVE INGREDIENT2968PHW8QPHYDROCORTISONE WITH ALOE MAXIMUM STRENGTH (HYDROCORTISONE) CREAM [ACTAVIS MID ATLANTIC LLC]2
CITRIC ACID MONOHYDRATEINACTIVE INGREDIENT2968PHW8QPHYDROCORTISONE MAXIMUM STRENGTH (HYDROCORTISONE) CREAM [PREFERRED PHARMACEUTICALS, INC.]2
GLYCERYL MONOSTEARATEINACTIVE INGREDIENT230OU9XXE4HYDROCORTISONE WITH ALOE MAXIMUM STRENGTH (HYDROCORTISONE) CREAM [ACTAVIS MID ATLANTIC LLC]2
GLYCERYL MONOSTEARATEINACTIVE INGREDIENT230OU9XXE4HYDROCORTISONE MAXIMUM STRENGTH (HYDROCORTISONE) CREAM [PREFERRED PHARMACEUTICALS, INC.]2
ISOPROPYL MYRISTATEINACTIVE INGREDIENT0RE8K4LNJSHYDROCORTISONE MAXIMUM STRENGTH (HYDROCORTISONE) CREAM [PREFERRED PHARMACEUTICALS, INC.]2
ISOPROPYL MYRISTATEINACTIVE INGREDIENT0RE8K4LNJSHYDROCORTISONE WITH ALOE MAXIMUM STRENGTH (HYDROCORTISONE) CREAM [ACTAVIS MID ATLANTIC LLC]2
METHYLPARABENINACTIVE INGREDIENTA2I8C7HI9THYDROCORTISONE WITH ALOE MAXIMUM STRENGTH (HYDROCORTISONE) CREAM [ACTAVIS MID ATLANTIC LLC]2
METHYLPARABENINACTIVE INGREDIENTA2I8C7HI9THYDROCORTISONE MAXIMUM STRENGTH (HYDROCORTISONE) CREAM [PREFERRED PHARMACEUTICALS, INC.]2
POLYOXYL 40 STEARATEINACTIVE INGREDIENT13A4J4NH9IHYDROCORTISONE MAXIMUM STRENGTH (HYDROCORTISONE) CREAM [PREFERRED PHARMACEUTICALS, INC.]2
POLYOXYL 40 STEARATEINACTIVE INGREDIENT13A4J4NH9IHYDROCORTISONE WITH ALOE MAXIMUM STRENGTH (HYDROCORTISONE) CREAM [ACTAVIS MID ATLANTIC LLC]2
POLYSORBATE 60INACTIVE INGREDIENTCAL22UVI4MHYDROCORTISONE MAXIMUM STRENGTH (HYDROCORTISONE) CREAM [PREFERRED PHARMACEUTICALS, INC.]2
POLYSORBATE 60INACTIVE INGREDIENTCAL22UVI4MHYDROCORTISONE WITH ALOE MAXIMUM STRENGTH (HYDROCORTISONE) CREAM [ACTAVIS MID ATLANTIC LLC]2
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3HYDROCORTISONE MAXIMUM STRENGTH (HYDROCORTISONE) CREAM [PREFERRED PHARMACEUTICALS, INC.]2
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3HYDROCORTISONE WITH ALOE MAXIMUM STRENGTH (HYDROCORTISONE) CREAM [ACTAVIS MID ATLANTIC LLC]2
PROPYLPARABENINACTIVE INGREDIENTZ8IX2SC1OHHYDROCORTISONE WITH ALOE MAXIMUM STRENGTH (HYDROCORTISONE) CREAM [ACTAVIS MID ATLANTIC LLC]2
PROPYLPARABENINACTIVE INGREDIENTZ8IX2SC1OHHYDROCORTISONE MAXIMUM STRENGTH (HYDROCORTISONE) CREAM [PREFERRED PHARMACEUTICALS, INC.]2
SODIUM CITRATEINACTIVE INGREDIENT1Q73Q2JULRHYDROCORTISONE WITH ALOE MAXIMUM STRENGTH (HYDROCORTISONE) CREAM [ACTAVIS MID ATLANTIC LLC]2
SODIUM CITRATEINACTIVE INGREDIENT1Q73Q2JULRHYDROCORTISONE MAXIMUM STRENGTH (HYDROCORTISONE) CREAM [PREFERRED PHARMACEUTICALS, INC.]2
SORBIC ACIDINACTIVE INGREDIENTX045WJ989BHYDROCORTISONE MAXIMUM STRENGTH (HYDROCORTISONE) CREAM [PREFERRED PHARMACEUTICALS, INC.]2
SORBIC ACIDINACTIVE INGREDIENTX045WJ989BHYDROCORTISONE WITH ALOE MAXIMUM STRENGTH (HYDROCORTISONE) CREAM [ACTAVIS MID ATLANTIC LLC]2
SORBITAN MONOSTEARATEINACTIVE INGREDIENTNVZ4I0H58XHYDROCORTISONE MAXIMUM STRENGTH (HYDROCORTISONE) CREAM [PREFERRED PHARMACEUTICALS, INC.]2
SORBITAN MONOSTEARATEINACTIVE INGREDIENTNVZ4I0H58XHYDROCORTISONE WITH ALOE MAXIMUM STRENGTH (HYDROCORTISONE) CREAM [ACTAVIS MID ATLANTIC LLC]2
STEARYL ALCOHOLINACTIVE INGREDIENT2KR89I4H1YHYDROCORTISONE WITH ALOE MAXIMUM STRENGTH (HYDROCORTISONE) CREAM [ACTAVIS MID ATLANTIC LLC]2
STEARYL ALCOHOLINACTIVE INGREDIENT2KR89I4H1YHYDROCORTISONE MAXIMUM STRENGTH (HYDROCORTISONE) CREAM [PREFERRED PHARMACEUTICALS, INC.]2
WATERINACTIVE INGREDIENT059QF0KO0RHYDROCORTISONE MAXIMUM STRENGTH (HYDROCORTISONE) CREAM [PREFERRED PHARMACEUTICALS, INC.]2
WATERINACTIVE INGREDIENT059QF0KO0RHYDROCORTISONE WITH ALOE MAXIMUM STRENGTH (HYDROCORTISONE) CREAM [ACTAVIS MID ATLANTIC LLC]2
WHITE WAXINACTIVE INGREDIENT7G1J5DA97FHYDROCORTISONE MAXIMUM STRENGTH (HYDROCORTISONE) CREAM [PREFERRED PHARMACEUTICALS, INC.]2
WHITE WAXINACTIVE INGREDIENT7G1J5DA97FHYDROCORTISONE WITH ALOE MAXIMUM STRENGTH (HYDROCORTISONE) CREAM [ACTAVIS MID ATLANTIC LLC]2

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
0472-0339-56004720339561 TUBE in 1 CARTON (0472-0339-56) > 28 g in 1 TUBE1 tube1997-09-012022-11-30NoNoCurrent